Os 240 melhores médicos de colonoscopia do mundo

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O Dr. Premkamol Patraithikul é um cirurgião geral com formação avançada em técnicas minimamente invasivas. O Dr. Patraithikul obteve o diploma de medicina na Universidade de Khon Kaen. O Dr. Patraithikul completou a residência em cirurgia geral na Universidade de Thammasat. O Dr. Patraithikul completou uma especialização em cirurgia laparoscópica na Universidade Mahidol (Hospital Siriraj), na Tailândia.

A experiência clínica inclui cirurgia laparoscópica e robótica. A prática também abrange cirurgia geral, cirurgia da obesidade e controle de peso, e cirurgia para condições gastrointestinais.

O Dr. Kim Taegyun é gastroenterologista. Ele concentra-se em doenças e cancros pancreatobiliares, incluindo pancreatite, quistos e cancro do pâncreas, colecistite, cálculos biliares (colelitíase) e cancro das vias biliares. Também realiza endoscopia avançada, incluindo CPRE. Trata tumores gastrointestinais, pólipos gástricos e do cólon, cancro do estômago e tumores submucosos (SMT).

Educação e formação: Doutor em Medicina, Faculdade de Medicina da Universidade Nacional de Jeonbuk. Mestrado em Medicina, Universidade de Ulsan. Internato, Hospital da Universidade Nacional de Jeonbuk. Residência em Medicina Interna, Centro Médico de Serviços de Saúde para Veteranos. Fellowships em Gastroenterologia, Hospital Inje University Haeundae Paik e Centro Médico Asan.

Carreira: Médico assistente e especialista no Hospital de Veteranos de Gwangju e no Centro Médico de Serviços de Saúde para Veteranos.

O Dr. Pak Seongjin é gastroenterologista. Ele foca em endoscopia e procedimentos avançados, como gastroscopia, colonoscopia, polipectomia e ESD. Ele também trata doenças digestivas e hepáticas, incluindo cirrose, pancreatite, hepatite e infecção por Helicobacter pylori.

Ele obteve seu doutorado em medicina e mestrado em Medicina Interna pela Universidade Chung-Ang. Concluiu sua residência em medicina interna e especialização em gastroenterologia no Hospital Universitário Chung-Ang.

Ele é professor clínico na Faculdade de Medicina da Universidade Gachon e na Faculdade de Medicina da Universidade Inha. É membro pleno da Associação Coreana de Medicina Interna, da Sociedade Coreana de Endoscopia Gastrointestinal, da Associação Coreana de Gastroenterologia e da Associação Coreana de Doenças Pancreatobiliares.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

O Professor Schoppmann chefia a Unidade de Tumores Gastroesofágicos no Hospital Geral de Viena. Ele é especializado na detecção e tratamento de pólipos gastrointestinais durante uma colonoscopia.

• Chefia o Departamento de Testes Funcionais Cirúrgicos na Universidade Médica de Viena
• Publicou mais de 240 artigos científicos sobre doenças do trato digestivo e pesquisa sobre câncer
• Atua como Secretário-Geral da Sociedade Austríaca de Oncologia Cirúrgica
• Editor de seção da revista médica European Surgery
• Especialista em cirurgia visceral com foco em condições complexas do sistema digestivo superior

O Dr. Arnulf Ferlitsch chefia o departamento de medicina interna. É um gastroenterologista premiado que presta serviços especializados de colonoscopia diagnóstica no Hospital Privado Döbling.

• Seis vezes vencedor do prémio Best Abstract Award da United European Gastroenterology Week
• Nomeado como "Rising Star" nacional em Gastroenterologia em 2012
• Especializado no tratamento de condições inflamatórias complexas como a doença de Crohn e a colite ulcerosa
• Concluiu a formação clínica na Universidade da Pensilvânia e na UCLA
• Fundou o laboratório de hemodinâmica hepática na Universidade Médica de Viena

A Dra. Nurana Guliyeva é gastroenterologista no Centro de Medicina Integrativa de Medicina Biológica em Baku. Ela é especializada no tratamento de hepatite viral, cirrose e doenças hepáticas autoimunes complexas. A Dra. Guliyeva completou um estágio em microbiologia e doenças infecciosas na Universidade Ege, na Turquia. Ela concentra-se na saúde digestiva, incluindo distúrbios do estômago, intestino e pâncreas.

• Formada na Universidade Ege e no Hospital Hacettepe, na Turquia.
• Trata hepatite viral A, B, C e D, além de intoxicação hepática induzida por medicamentos.
• Realiza procedimentos especializados como hidroterapia de cólon e remoção de pólipos gástricos.
• Trabalha num centro de saúde integrativo que trata mais de 84.000 pacientes anualmente.

O médico é um cirurgião altamente especializado com vasta experiência em procedimentos oncológicos e metabólicos. O foco clínico abrange uma ampla gama de cirurgias oncológicas, incluindo intervenções complexas para neoplasias do pâncreas, vias biliares, estômago, cólon e tireoide, bem como cirurgia mamária especializada.

Além da oncologia, o médico é proficiente em cirurgia bariátrica e metabólica, fornecendo soluções cirúrgicas avançadas para o controle da obesidade e do diabetes. A prática dedica-se a oferecer cuidados cirúrgicos abrangentes, utilizando técnicas baseadas em evidências para tratar tanto condições malignas quanto distúrbios metabólicos.

O professor Gerhard Prager dirige a clínica de obesidade do Hospital Geral de Viena. Ele utiliza a colonoscopia para avaliar a saúde digestiva em pacientes metabólicos.

• Chefe do Centro de Cirurgia Metabólica do Hospital Privado Confraternitaet
• Especialista em gastroenterologia e cirurgia para obesidade e diabetes
• Presidente do Capítulo Europeu da Federação Internacional de Cirurgia da Obesidade
• Membro da Sociedade Americana de Cirurgia Metabólica e Bariátrica
• Especialista na avaliação de úlceras gástricas e condições internas

O médico é um especialista experiente em radiologia intervencionista, com um foco clínico dedicado à imagiologia e intervenções da tiroide e da próstata. Com uma base académica sólida da Faculdade de Medicina da Universidade de Istambul Cerrahpaşa e uma formação de residência especializada em radiologia no Hospital de Formação e Investigação S.B. Haydarpaşa Numune, o médico traz uma vasta experiência para a área.

Ao longo de uma carreira distinta, o médico contribuiu para a prática clínica em instituições como o Hospital da Universidade Başkent de Istambul e o Hospital de Formação e Investigação S.B. Haydarpaşa Numune. Além disso, o médico possui formação em gestão de saúde pela Universidade de Anadolu e mantém membros profissionais ativos na Câmara Médica de Istambul e na Sociedade de Radiologia de Istambul.

O Dr. Yaacov Lawrence é o Chefe de Oncologia Radioterápica no Centro Médico Sheba. Ele é especializado em radioterapia de precisão e neuro-oncologia. O Dr. Lawrence foi pioneiro na radiocirurgia do plexo celíaco para o controle da dor no câncer de pâncreas. Ele possui a designação FASTRO, uma das mais altas honrarias em sua especialidade.

• Lidera o Programa de Câncer Gastrointestinal no Centro Médico Sheba.
• Realiza radiocirurgia estereotática para tumores cerebrais e cânceres do sistema nervoso.
• Autor de mais de 280 publicações científicas sobre protocolos de radiação personalizados.
• Concluiu o treinamento de fellowship em oncologia radioterápica na Universidade Thomas Jefferson.

O Dr. Jair Bar é oncologista torácico e vice-diretor do Centro de Câncer do Sheba Medical Center. Ele é especializado no tratamento de câncer de pulmão de células não pequenas avançado usando imunoterapia personalizada e tratamentos direcionados. O Dr. Bar possui doutorado em Biologia Molecular e lidera um laboratório de pesquisa focado em resistência à imunoterapia.

• Presidente do Grupo Israelense de Câncer de Pulmão.
• Certificado em Oncologia Médica e Radioterapia Oncológica.
• Trata pacientes no Sheba Medical Center, um dos 10 melhores hospitais do mundo.
• Usa perfil molecular e genético para criar planos precisos de tratamento contra o câncer.

O Dr. Raanan Berger é o diretor do Centro de Câncer do Sheba Medical Center. Ele foi incluído na lista de "Melhores Médicos" da Forbes Israel em 2025. O Dr. Berger é especializado em oncologia geniturinária e trata tumores complexos de próstata com radioterapia. Ele completou um pós-doutorado no Dana-Farber/Harvard Cancer Institute.

• Chefia a unidade de pesquisa clínica focada em oncologia molecular.
• Coautor de mais de 20 artigos revisados por pares sobre câncer de próstata e mutações BRCA.
• Membro da Sociedade Americana de Oncologia Clínica (ASCO).
• Realiza terapia sistêmica e radioterapia em um hospital classificado entre os 10 melhores do mundo.

O Prof. Boursi desenvolveu modelos preditivos para o diagnóstico precoce do cancro colorretal. Ele lida com oncologia gastrointestinal e rastreios de colonoscopia no Sheba Medical Center.

• Formado em oncologia no MD Anderson Cancer Center e na Mayo Clinic
• Concluiu uma bolsa de oncologia gastrointestinal na Universidade da Pensilvânia
• Fundou o Grupo de Trabalho de Microbioma da ECOG-ACRIN para estudar o desenvolvimento do cancro
• Membro da Associação Israelita de Oncologia Clínica e Radioterapia
• Publicou pesquisas na revista Science sobre a resposta ao tratamento do cancro

A Dra. Tülin Kendir Koçak é especialista em gastroenterologia no Hospital Emsey. Ela utiliza técnicas avançadas de rastreio, como a colonoscopia, para examinar o intestino grosso e o reto.

• Realiza cromoendoscopia – utiliza corantes especializados para melhor visualizar e encontrar tecidos anormais
• Especializada em tratamentos intervencionistas – incluindo a remoção de pólipos e corpos estranhos
• Especialista em medicina interna e gastroenterologia formada em grandes hospitais de formação e investigação turcos
• Trata condições digestivas complexas – incluindo a doença de Crohn, cirrose e hemorragias gastrointestinais